SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000899140-21-000699
Filing Date
2021-11-01
Accepted
2021-11-01 09:27:12
Documents
1
Group Members
INNOVIVA STRATEGIC OPPORTUNITIES LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A (AMENDMENT NO. 5) a102921a.htm SC 13D/A 54104
  Complete submission text file 0000899140-21-000699.txt   56139
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Subject) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-44887 | Film No.: 211365585
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filed by) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations